Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 26, 2017
- Accepted for publication December 15, 2017
- Published online April 2, 2018.
Article Versions
- previous version (January 11, 2018 - 12:27).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Dale L. Bailey1,2,
- Michael S. Hofman3,
- Nicholas J. Forwood1,2,
- Graeme J. O’Keefe4,
- Andrew M. Scott4,5,
- Winifred M. van Wyngaardt6,
- Bonnie Howe6,
- Olga Kovacev7 and
- Roslyn J. Francis7,8
- on behalf of ARTnet7
- and the ProPSMA Trial Investigators
- 1Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia
- 2Faculty of Health Sciences, University of Sydney, Sydney, Australia
- 3Molecular Imaging, Department of Cancer Imaging, Peter MacCallum Cancer Institute, Melbourne, Australia
- 4Department of Molecular Imaging and Therapy, Austin Health, and University of Melbourne, Melbourne, Australia
- 5Olivia Newton-John Cancer Research Institute and La Trobe University, Melbourne, Australia
- 6Radionuclide Metrology Group, Nuclear Stewardship, ANSTO, Sydney, Australia
- 7Australasian Radiopharmaceutical Trials Network (ARTnet), Australia; and
- 8Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia
- For correspondence or reprints contact: Dale L. Bailey, Department of Nuclear Medicine, Royal North Shore Hospital, St. Leonards, Sydney, Australia 2065. E-mail: dale.bailey{at}sydney.edu.au
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study
- A Method for Validating PET and SPECT Cameras for Quantitative Clinical Imaging Trials Using Novel Radionuclides
- Acquisition Duration Optimization Using Visual Grading Regression in [68Ga]FAPI-46 PET Imaging of Oncologic Patients
- Dosimetry in Radiopharmaceutical Therapy
- Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
- The Australasian Radiopharmaceutical Trials Network: Clinical Trials, Evidence, and Opportunity
- ProPSMA: A Callout to the Nuclear Medicine Community to Change Practices with Prospective, High-Quality Data